416 related articles for article (PubMed ID: 9574634)
1. Survival and functional status after resection of recurrent glioblastoma multiforme.
Barker FG; Chang SM; Gutin PH; Malec MK; McDermott MW; Prados MD; Wilson CB
Neurosurgery; 1998 Apr; 42(4):709-20; discussion 720-3. PubMed ID: 9574634
[TBL] [Abstract][Full Text] [Related]
2. Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years.
Mukherjee S; Wood J; Liaquat I; Stapleton SR; Martin AJ
Clin Neurol Neurosurg; 2020 Jan; 188():105568. PubMed ID: 31739155
[TBL] [Abstract][Full Text] [Related]
3. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
[TBL] [Abstract][Full Text] [Related]
6. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
[TBL] [Abstract][Full Text] [Related]
7. Experiences with reoperation on recurrent glioblastoma multiforme.
Pinsker M; Lumenta C
Zentralbl Neurochir; 2001; 62(2):43-7. PubMed ID: 11786935
[TBL] [Abstract][Full Text] [Related]
8. Residual tumor volume and patient survival following reoperation for recurrent glioblastoma.
Yong RL; Wu T; Mihatov N; Shen MJ; Brown MA; Zaghloul KA; Park GE; Park JK
J Neurosurg; 2014 Oct; 121(4):802-9. PubMed ID: 25061868
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
10. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
[TBL] [Abstract][Full Text] [Related]
11. The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Li YM; Suki D; Hess K; Sawaya R
J Neurosurg; 2016 Apr; 124(4):977-88. PubMed ID: 26495941
[TBL] [Abstract][Full Text] [Related]
12. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.
Shrieve DC; Alexander E; Black PM; Wen PY; Fine HA; Kooy HM; Loeffler JS
J Neurosurg; 1999 Jan; 90(1):72-7. PubMed ID: 10413158
[TBL] [Abstract][Full Text] [Related]
13. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
14. Management of glioblastoma multiforme: with special reference to recurrence.
Durmaz R; Erken S; Arslantaş A; Atasoy MA; Bal C; Tel E
Clin Neurol Neurosurg; 1997 May; 99(2):117-23. PubMed ID: 9213056
[TBL] [Abstract][Full Text] [Related]
15. Is reoperation for recurrence of glioblastoma justified?
Guyotat J; Signorelli F; Frappaz D; Madarassy G; Ricci AC; Bret P
Oncol Rep; 2000; 7(4):899-904. PubMed ID: 10854567
[TBL] [Abstract][Full Text] [Related]
16. Multiple resections for patients with glioblastoma: prolonging survival.
Chaichana KL; Zadnik P; Weingart JD; Olivi A; Gallia GL; Blakeley J; Lim M; Brem H; Quiñones-Hinojosa A
J Neurosurg; 2013 Apr; 118(4):812-20. PubMed ID: 23082884
[TBL] [Abstract][Full Text] [Related]
17. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.
Kondziolka D; Flickinger JC; Bissonette DJ; Bozik M; Lunsford LD
Neurosurgery; 1997 Oct; 41(4):776-83; discussion 783-5. PubMed ID: 9316038
[TBL] [Abstract][Full Text] [Related]
18. Primary glioblastoma multiforme in younger patients: a single-institution experience.
Ulutin C; Fayda M; Aksu G; Cetinayak O; Kuzhan O; Ors F; Beyzadeoglu M
Tumori; 2006; 92(5):407-11. PubMed ID: 17168433
[TBL] [Abstract][Full Text] [Related]
19. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection.
Elliott RE; Parker EC; Rush SC; Kalhorn SP; Moshel YA; Narayana A; Donahue B; Golfinos JG
World Neurosurg; 2011; 76(1-2):128-40; discussion 61-2. PubMed ID: 21839964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]